Turning Point Therapeutics Inc. (TPTX)

This company is not actively trading or the ticker does belong to another company in our database now.

Sector: Pharmaceutical Preparations

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on August 21, 2026, 5:28pm based on SEC 13F filings Last update: August 21, 2026, 5:28pm

No.	Hedge Fund	Value	% Port
1.	Trexquant Investment LP Tyger (Taesoon) Park	$0	0%
2.	Olympiad Research LP Thong Nguyen	$0	0%
3.	Shay CapitalPUT Samuel Ginzburg	$0	0%
4.	Shay Capital Samuel Ginzburg	$0	0%
5.	Fifth Lane Capital Cavan Copeland	$0	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Alles Director	$81.34	2,000	$162,680.00	2,000	2021-06-21	Filing
George Director	$60.00	83,333	$4,999,980.00	2,253,660	2020-05-21	Filing
Countouriotis Officer, Director	$60.00	4,166	$249,960.00	26,872	2020-05-21	Filing
Glaxosmithkline Director	$60.00	83,333	$4,999,980.00	2,253,660	2020-05-21	Filing
Glaxosmithkline Director	$45.00	177,777	$7,999,965.00	2,170,327	2019-09-10	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Tombesi Officer	$74.94	1,183	$88,654.02	28,700	2022-07-27	Filing
Reich Officer	$36.30	397	$14,411.10	3,448	2022-02-09	Filing
Partridge Officer	$36.30	221	$8,022.30	22,078	2022-02-09	Filing
North Officer	$36.30	669	$24,284.70	11,696	2022-02-09	Filing
Hirmand Officer	$36.30	669	$24,284.70	6,838	2022-02-09	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Value	% Port
1.	Advisors Asset Management, Inc.	$0	0%
2.	Erste Asset Management Gmbh	$0	0%
3.	Prudential Financial Inc	$0	0%
4.	Goldman Sachs Group Inc	$0	0%
5.	Metlife Investment Advisors, Llc	$0	0%